±ÒÓ®¹ÙÍø

  • EN
EN

ÐÅÏ¢ÖÐÐÄ

Information Center

ÐÐÒµ¶¯Ì¬

JEM£º£º£ºÐÂ×êÑнÒʾÒҸβ¡¶¾µÄÖ²¡»úÖÆ

°ä²¼¹¦·ò2020-08-21  |  µã»÷ÂÊ£º£º£º

·ÖÏíµ½£º£º£º

ÒÒÐ͸ÎÑײ¡¶¾£¨HBV£©ÒýÆðµÄϰȾÊÇĿǰȫÇòÁìÓòÄÚÖØÒªµÄ¹«¹²ÎÀÉúÎÊÌâ¡£¡£Ö»¹ÜÓÐÓÐЧµÄ±£»£»£»¤ÐÔÒßÃ磬ƾ¾ÝÊÀ½çÎÀÉú×éÖ¯µÄ¹À¼Æ£¬È«ÊÀ½çÈÔÓг¬¹ý2.5ÒÚÈË´æÔÚÂýÐÔϰȾ¡£¡£HBVϰȾÓë¸ÎÓ²»¯£¬¸ÎË¥½ßºÍ¸Îϸ°û°©ÓйØ£¬Ã¿Äêµ¼ÖÂÔ¼100ÍòÈËéæÃü¡£¡£Æù½ñΪֹ£¬ÉÐÎÞÄÜÆëÈ«½â³ý¸Ã²¡¶¾²¢ÎªÂýÐÔHBVϰȾÌṩҽÖεÄÌØÒìÐÔ²½Öè¡£¡£ 

W020200820338951964774.jpg

ͼƬÆðÔ´£º£º£º(www.pixabay.com) ¡¡¡¡

¡¡¡¡ÎªÁËÍÆ½øÆ¥µÐHBVϰȾµÄ¿¹ÌåÓ¦´ð·´Ó³µÄÏàʶ£¬°Í˹µÂ×êÑÐËù£¨Institut Pasteur and Inserm£©µÄ¿ÆÑ§¼ÒÓëÈðÊ¿ÂÞÊÏ´´ÐÂÖÐÐÄ£¨Roche Innovation Center£©ºÏ×÷£¬´ÓHBVÒßÃç½ÓÖÖÕߺÍÌìÈ»¿µ¸´»¼ÕßѪҺÖзÖÀë³öÁËÓ°ÏóBϸ°û£¬²¢ÇÒ³ö²ú¡¢¡¢¼ø¶¨ÁËÕë¶Ô²¡¶¾±»Ä¤¿¹Ô­£¨HBsAg£©µÄÈ˵¥¿Ë¡¿¹Ìå¡£¡£ 

¡¡¡¡ÎªÁË×êÑÐÕë¶ÔÒÒÐ͸ÎÑײ¡¶¾Ï°È¾µÄ±£»£»£»¤×÷ÓõĿ¹ÌåÓ¦´ð£¬²¢¾ßÌå·ÖÎöÕë¶Ô¸Ã²¡¶¾µÄ¿¹ÌåµÄ¸öÐÔ£¬°Í˹µÂÃâÒßѧ³¢ÊÔÊÒÓëÈðÊ¿ÂÞÊÏ´´ÐÂÖÐÐĺÏ×÷£¬³ö²ú²¢¼ø¶¨ÁËÔ¼100ÖÖHBVÀíÂÛ¿¹Ô­£¨HBsAg£©ÌØÒìÐÔµÄÈ˵¥¿Ë¡¿¹Ìå¡£¡£ 

¡¡¡¡°Í˹µÂ×êÑÐËùÌåÒºÃâÒßѧ³¢ÊÔÊÒÕÆ¹ÜÈË£¬×êÑÐÈËÔ±Hugo MouquetÚ¹ÊÍ˵£º£º£º×êÑÐÅú×¢£¬½ÓÖÖÒßÃç»òÌìȻϰȾ¿µ¸´¸ö±ðÌåÄÚ»á²úÉúÕë¶ÔHBsAgµÄ·ÖÆçÇøÓòµÄ¸÷Àà¸÷ÑùµÄ¿¹Ìå¡£¡£ÔÚ¿µ¸´»¼ÕßÌåÄÚ²úÉúµÄ¾ø´óÎÞÊý¿¹HBsAg¿¹ÌåÓµÓÐÖкÍ×÷Ó㬿ÉÄÜÓëÊÀ½ç¸÷µØÊ¢ÐÐµÄ·ÖÆçHBVÑÇÐÍ·´Ó³¡£¡£³ýÁËÔÚµÍŨ¶ÈÏÂÓµÓÐÌåÍâÖкÍÄÜÁ¦Í⣬HBVϰȾСÊóÄ£ÐÍÖвâÊÔÁ˾ÖÅú×¢£¬ºòÑ¡¿¹Ìå·Ö×Ó»¹ÓÐÖúÓÚÌåÄÚ²¡¶¾ÑªÖ¢µÄ´ó·ù½µÂä¡£¡£ÆäÖУ¬·ÖÀëµÃµ½µÄ¹ãÆ×ÐÔÖкͿ¹ÌåBc1.187ÍÆ½øÁËϰȾHBVСÊóµÄ²¡¶¾ÑªÖ¢Ö¢×´ÏÔÖø»º½â£¬ÔÚijЩСÊóÖУ¬Ï°È¾µÃµ½Á˳־õĽÚÖÆ¡£¡£ 

¡¡¡¡Hugo Mouquet˵£º£º£ºÒò¶ø£¬Õë¶ÔHBsAgµÄÖкͿ¹ÌåËÆºõÔÚÂýÐÔϰȾ»¼ÕߵĿµ¸´¹ý³ÌÖÐÆð¹Ø¼ü×÷Óã¬ÆäÖУ¬¿¹ÌåBc1.187ÊÇÒ»ÖÖÓÃÓÚÒ½ÖÎÂýÐÔHBVϰȾ»¼ÕßµÄDZÔÚ¹¤¾ß¡£¡£ 

   £¨ÆðÔ´£º£º£ºÐÔÃü¿ÆÑ§Ç°ÑØ£© 

¡¡¡¡Ô­Îijö´¦£º£º£ºVerena Hehle et al, Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers, Journal of Experimental Medicine (2020). DOI: 10.1084/jem.20200840 

¡¡¡¡Á´½Ó£º£º£ºhttps://pubmed.ncbi.nlm.nih.gov/32579155/ 

¡¾ÍøÕ¾µØÍ¼¡¿